Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort
- PMID: 32974170
- PMCID: PMC7469928
- DOI: 10.3389/fonc.2020.01457
Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort
Abstract
Esophageal squamous cell carcinoma (ESCC) is the most common histological subtype of esophageal cancer in India. Cigarette smoking and chewing tobacco are known risk factors associated with ESCC. However, genomic alterations associated with ESCC in India are not well-characterized. In this study, we carried out exome sequencing to characterize the mutational landscape of ESCC tumors from subjects with a varied history of tobacco usage. Whole exome sequence analysis of ESCC from an Indian cohort revealed several genes that were mutated or had copy number changes. ESCC from tobacco chewers had a higher frequency of C:G > A:T transversions and 2-fold enrichment for mutation signature 4 compared to smokers and non-users of tobacco. Genes, such as TP53, CSMD3, SYNE1, PIK3CA, and NOTCH1 were found to be frequently mutated in Indian cohort. Mutually exclusive mutation patterns were observed in PIK3CA-NOTCH1, DNAH5-ZFHX4, MUC16-FAT1, and ZFHX4-NOTCH1 gene pairs. Recurrent amplifications were observed in 3q22-3q29, 11q13.3-q13.4, 7q22.1-q31.1, and 8q24 regions. Approximately 53% of tumors had genomic alterations in PIK3CA making this pathway a promising candidate for targeted therapy. In conclusion, we observe enrichment of mutation signature 4 in ESCC tumors from patients with a history of tobacco chewing. This is likely due to direct exposure of esophagus to tobacco carcinogens when it is chewed and swallowed. Genomic alterations were frequently observed in PIK3CA-AKT pathway members independent of the history of tobacco usage. PIK3CA pathway can be potentially targeted in ESCC which currently has no effective targeted therapeutic options.
Keywords: esophageal cancer; mutation signatures; squamous cell carcinoma; tobacco; whole exome sequencing.
Copyright © 2020 Mangalaparthi, Patel, Khan, Manoharan, Karunakaran, Murugan, Gupta, Gupta, Khanna-Gupta, Chaudhuri, Kumar, Nair, Kumar, Prasad, Chatterjee, Pandey and Gowda.
Figures






Similar articles
-
Whole-Exome Sequencing Analysis of Oral Squamous Cell Carcinoma Delineated by Tobacco Usage Habits.Front Oncol. 2021 May 31;11:660696. doi: 10.3389/fonc.2021.660696. eCollection 2021. Front Oncol. 2021. PMID: 34136393 Free PMC article.
-
Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma.PeerJ. 2020 Jun 26;8:e9294. doi: 10.7717/peerj.9294. eCollection 2020. PeerJ. 2020. PMID: 32617189 Free PMC article.
-
Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.Am J Hum Genet. 2015 Apr 2;96(4):597-611. doi: 10.1016/j.ajhg.2015.02.017. Am J Hum Genet. 2015. PMID: 25839328 Free PMC article.
-
Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.World J Gastroenterol. 2016 Feb 21;22(7):2284-93. doi: 10.3748/wjg.v22.i7.2284. World J Gastroenterol. 2016. PMID: 26900290 Free PMC article. Review.
-
Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma.Gastroenterology. 2015 Dec;149(7):1700-15. doi: 10.1053/j.gastro.2015.08.054. Epub 2015 Sep 12. Gastroenterology. 2015. PMID: 26376349 Review.
Cited by
-
Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma.Front Cell Dev Biol. 2022 Jan 20;9:787766. doi: 10.3389/fcell.2021.787766. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35127708 Free PMC article.
-
Early NOTCH1 mutation is positively selected but epistatically suppresses evolution of later esophageal squamous-cell carcinoma drivers.bioRxiv [Preprint]. 2025 Jun 25:2023.11.03.565535. doi: 10.1101/2023.11.03.565535. bioRxiv. 2025. PMID: 40667321 Free PMC article. Preprint.
-
Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts.J Cancer. 2021 May 10;12(13):3930-3944. doi: 10.7150/jca.52286. eCollection 2021. J Cancer. 2021. PMID: 34093800 Free PMC article.
-
Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma.Front Mol Biosci. 2022 Jan 21;8:792779. doi: 10.3389/fmolb.2021.792779. eCollection 2021. Front Mol Biosci. 2022. PMID: 35127817 Free PMC article.
-
Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.Front Oncol. 2021 Aug 27;11:729418. doi: 10.3389/fonc.2021.729418. eCollection 2021. Front Oncol. 2021. PMID: 34513706 Free PMC article.
References
-
- Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. . Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. (2017) 3:524–48. 10.1001/jamaoncol.2016.5688 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous